Dennis Langer - Insider Trading & Ownership

Entity
Individual
Location
C/O Peter Tsoflias, Blank Rome Llp, One Logan Square, Fl 9, Philadelpha, PA
Summary
The estimated net worth of Dennis Langer is at least $2.04M dollars as of June 10, 2024. Dennis Langer is the Director of MYRIAD GENETICS INC and owns shares of MYRIAD GENETICS INC (MYGN) stock worth about $2.04M. Dennis Langer is the Director of Quoin Pharmaceuticals, Ltd. and owns shares of Quoin Pharmaceuticals, Ltd. (QNRX) stock worth about $39.00.
All Insider Reports
All Insider Reports

Ownership of Dennis Langer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MYGN MYRIAD GENETICS INC Director $2.04M Jun 30, 2022
QNRX Quoin Pharmaceuticals, Ltd. Director $39.00 -$217 -84.8% Jun 7, 2024
ERNA Eterna Therapeutics Inc. Director Dec 8, 2021

Insider Transactions Reported by Dennis Langer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.